Wisconsin's Waisman Center will conduct human clinical trials with stem cells, including a first-of-its-kind spinal stem cell trial, the report says. The tests on patients with spinal injuries will begin in six months. The study will help the push toward the "development of treatments for prevalent diseases using stem cells," the Badger Herald says.
"Our main function is to understand how to manufacture biological products and biotechnology drugs in a way that can go into human clinical trials," Derek Hei, a biochemical engineer who is the Waisman Center's technical director, said in a statement. "We also help investigators follow and interpret Food and Drug Administration rules as they move into clinical trials."
Searching for a college? Get our complete rankings of America's Best Colleges.